FARALLON CAPITAL MANAGEMENT LLC Q3 2018 Filing
Filed November 14, 2018
Portfolio Value
$16.9B
Holdings
102
Report Date
Q3 2018
Filing Type
13F-HR
All Holdings (102 positions)
| Stock | Value |
|---|---|
SPYSPDR S&P 500 ETF TR | $2.7B |
—AETNA INC NEW | $1.5B |
AABAUSDALTABA INC | $1.4B |
—EXPRESS SCRIPTS HLDG CO | $1.1B |
DELLDELL TECHNOLOGIES INC | $620.5M |
—ROCKWELL COLLINS INC | $583.7M |
METAFACEBOOK INC | $408.8M |
IQVIQVIA HLDGS INC | $394.3M |
CHTRCHARTER COMMUNICATIONS INC N | $385.5M |
GOOGALPHABET INC | $375.6M |
WABWABTEC CORP | $367.1M |
GDGENERAL DYNAMICS CORP | $362.5M |
VVISA INC | $296.2M |
PLYAPLAYA HOTELS & RESORTS NV | $294.7M |
TLRYEURTILRAY INC | $285.5M |
ELVANTHEM INC | $283.6M |
—IHS MARKIT LTD | $272.8M |
EQIXEQUINIX INC | $263.5M |
—ENVISION HEALTHCARE CORP | $256.8M |
BKNGBOOKING HLDGS INC | $254.5M |
TRUTRANSUNION | $252.2M |
MSFTMICROSOFT CORP | $246.9M |
FOXATWENTY FIRST CENTY FOX INC | $245.6M |
FISFIDELITY NATL INFORMATION SV | $214.0M |
CTXSEURCITRIX SYS INC | $201.5M |
LBTYBLIBERTY GLOBAL PLC | $196.9M |
LBTYBLIBERTY GLOBAL PLC | $191.8M |
VRSKVERISK ANALYTICS INC | $171.7M |
BPYPNBROOKFIELD PROPERTY REIT INC | $168.6M |
NXPINXP SEMICONDUCTORS N V | $141.1M |
AZNASTRAZENECA PLC | $135.3M |
EFXEQUIFAX INC | $106.5M |
XLRNACCELERON PHARMA INC | $105.3M |
ASNDASCENDIS PHARMA A S | $103.3M |
—MYOKARDIA INC | $99.8M |
—ZOGENIX INC | $89.1M |
SG7SAGE THERAPEUTICS INC | $88.3M |
FGENEURFIBROGEN INC | $84.7M |
—SINA CORP | $78.1M |
ARRYEURARRAY BIOPHARMA INC | $77.9M |
AVAAVISTA CORP | $74.3M |
ENTAENANTA PHARMACEUTICALS INC | $74.1M |
NVCRNOVOCURE LTD | $70.7M |
—TWENTY FIRST CENTY FOX INC | $66.5M |
BABAALIBABA GROUP HLDG LTD | $61.5M |
CLSCA INC | $61.0M |
RETAEURREATA PHARMACEUTICALS INC | $55.1M |
AMRNAMARIN CORP PLC | $53.9M |
IOVAIOVANCE BIOTHERAPEUTICS INC | $53.2M |
GBTUSDGLOBAL BLOOD THERAPEUTICS IN | $52.1M |
CRSPCRISPR THERAPEUTICS AG | $45.2M |
MRTXEURMIRATI THERAPEUTICS INC | $41.2M |
GRFSGRIFOLS S A | $38.3M |
—SUTHERLAND ASSET MGMT CORP M | $36.7M |
—RADIUS HEALTH INC | $36.4M |
SRPTSAREPTA THERAPEUTICS INC | $31.5M |
—INTEGRATED DEVICE TECHNOLOGY | $30.1M |
YB4PSAVARA INC | $27.0M |
BUDANHEUSER BUSCH INBEV SA/NV | $25.7M |
ALNYALNYLAM PHARMACEUTICALS INC | $24.2M |
—AVROBIO INC | $24.1M |
PTGXPROTAGONIST THERAPEUTICS INC | $23.1M |
—PROGENICS PHARMACEUTICALS IN | $22.7M |
—PTC THERAPEUTICS INC | $21.1M |
—ZYMEWORKS INC | $21.0M |
PTCTPTC THERAPEUTICS INC | $19.7M |
—APTINYX INC | $19.4M |
EX9EXELIXIS INC | $19.1M |
—ZAFGEN INC | $19.0M |
PBYIPUMA BIOTECHNOLOGY INC | $18.8M |
VYGRVOYAGER THERAPEUTICS INC | $17.2M |
CDXSCODEXIS INC | $17.1M |
—BROOKFIELD PPTY PARTNERS L P | $16.6M |
—SHIRE PLC | $15.8M |
NTLAINTELLIA THERAPEUTICS INC | $15.7M |
—ZEALAND PHARMA A S | $14.9M |
CCXIEURCHEMOCENTRYX INC | $14.5M |
SLDBSOLID BIOSCIENCES INC | $13.9M |
—ORBOTECH LTD | $13.7M |
DVAXDYNAVAX TECHNOLOGIES CORP | $13.3M |
—BELLICUM PHARMACEUTICALS INC | $13.2M |
CHRSCOHERUS BIOSCIENCES INC | $11.6M |
ASMBASSEMBLY BIOSCIENCES INC | $11.1M |
—BEMIS INC | $10.0M |
VOYAVOYA FINL INC | $9.2M |
FATEFATE THERAPEUTICS INC | $8.6M |
—ENDOCYTE INC | $7.1M |
ITCIEURINTRA CELLULAR THERAPIES INC | $5.4M |
—SOLARCITY CORP | $4.9M |
—TRANSLATE BIO INC | $4.5M |
KALVKALVISTA PHARMACEUTICALS INC | $4.4M |
SPPIUSDSPECTRUM PHARMACEUTICALS INC | $4.2M |
CRNXCRINETICS PHARMACEUTICALS IN | $4.1M |
SNYSANOFI | $3.8M |
—PRINCIPIA BIOPHARMA INC | $3.7M |
YMABUSDY MABS THERAPEUTICS INC | $3.3M |
—PFENEX INC | $3.1M |
—ARQULE INC | $2.8M |
—RA MED SYS INC | $2.7M |
STROSUTRO BIOPHARMA INC | $2.3M |
Page 1 of 2Next